Conference to Focus on Prevention, Testing and Care Strategies Company Supports Recent CDC & USPSTF Routine Testing Recommendations MEDFORD, N.Y. , Nov. 27, 2012 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today
Expects Record Revenue and Continued Profitability for the Fourth Quarter and Full Year Conference Call Begins at 10:00 a.m. Eastern Time Today MEDFORD, N.Y., Nov. 13, 2012 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious
Conference Call Scheduled for Tuesday, November 13th at 10:00 a.m. Eastern Time; Company Fully Resumes Operations Following Two Day Hurricane Sandy Shutdown
MEDFORD, N.Y. , Sept. 25, 2012 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced that Lawrence Siebert , the Company's President and Chief Executive Officer, will present a corporate overview at the
MEDFORD, N.Y., Sept. 12, 2012 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, today announced the appointment of Sharon Klugewicz as Vice President of Quality Assurance/Quality Control ("QA/QC") and Technical
MEDFORD, N.Y. , Aug. 21, 2012 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq:CEMI), a leader in point-of-care diagnostic tests for infectious diseases, announces the appointment of Michael Steele as Vice President of Sales, Marketing & Business Development, a newly created position. Mr.
Print Page